Financial Statements — BCG
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Cash & Equivalents | 10.53 | 8.34 | 8.17 | 8.82 | 7.25 | 7.03 | 6.18 |
| Total Assets | 71.25 | 67.56 | 67.79 | 67.88 | 66.96 | 66.06 | 65.83 |
| Total Liabilities | 50.83 | 49.47 | 51.40 | 50.87 | 49.48 | 48.76 | 48.01 |
| Retained Earnings | (20.59) | (21.11) | (22.87) | (22.22) | (22.16) | (21.01) | (20.27) |
| Total Stockholder Equity* | 20.42 | 18.10 | 16.39 | 17.01 | 17.49 | 17.31 | 17.82 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | 1.06 |
| Pretax Income | 2.66 | (0.23) | 1.95 | (0.56) | 1.46 | (0.57) | (0.61) | (0.52) | (1.44) |
| Tax Provision | 0.76 | -- | 0.19 | 0.09 | 0.42 | 0.53 | 0.54 | 0.21 | 0.14 |
| Net Income | 1.90 | 0.17 | 1.76 | (0.65) | 1.03 | (1.09) | (1.15) | (0.74) | (2.31) |
| Basic EPS | 0.09 | (0.05) | 0.08 | (0.04) | 0.06 | (0.07) | (0.07) | (0.04) | (0.14) |
| Diluted EPS | 0.09 | (0.06) | 0.08 | (0.04) | 0.06 | (0.07) | (0.07) | (0.04) | (0.14) |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 |
|---|
| Operating Cash Flow | 0.54 | 3.10 | 0.93 | 0.06 | 1.05 | 1.79 | (0.30) | (0.18) | (3.14) |
| Capital Expenditures | 0.01 | 0.01 | 0.05 | 0.00 | 0.01 | 0.07 | 0.00 | (0.07) | 0.01 |
| Free Cash Flow* | 0.53 | 3.10 | 0.88 | 0.06 | 1.05 | 1.73 | (0.30) | (0.11) | (3.15) |
| Investing Cash Flow | (0.01) | (0.01) | (0.05) | 0.00 | (0.01) | (0.07) | 0.00 | (0.01) | (0.01) |
| Financing Cash Flow | (0.72) | (0.72) | (0.71) | (0.71) | (0.71) | (0.49) | 0.53 | (0.17) | 1.71 |
* Derived from reported values
